Convergent Validity of DABQ Questionnaire
DABQ
Convergent Validity of the DABQ Questionnaire With the Actigraph as Reference Method to Assess 24-hour Movement Behaviors Among Adults
1 other identifier
interventional
100
1 country
1
Brief Summary
Time-use epidemiology is a rapidly growing research area that aims to understand how individuals allocate their time to various activities throughout the day. Accurate assessment of daily activity behaviors, such as sleep, sedentary behavior (SB), light physical activity (LPA), and moderate to vigorous physical activity (MVPA), is crucial for studying the associations between activity patterns and health outcomes. To gather this information, researchers often rely on self-report questionnaires and objective measures, such as accelerometers, to provide a comprehensive understanding of individuals' activity levels. Recently, a validated questionnaire known as the Daily Activity Behavior Questionnaire (DABQ) has been developed. In a study comparing DABQ estimates with the activPAL4 accelerometer (as the reference method), good results regarding absolute agreement and consistency were obtained for sleep duration (ICC 0.6), while the absolute agreement and consistency for SB, LPA, and MVPA estimates was lower (ICC ranging from 0.22-0.47). It should be noted that this study acknowledges the limitation of not treating the data as compositional data. Compositional data analysis accounts for the relative distribution of different activities and avoids the assumption of independence between behaviors. Additionally, the activPAL4 accelerometer used as the reference method in the study had its own strengths and weaknesses when compared to other objective measures, such as the Actigraph. Where ActivPAL4 is more used to differentiate between sitting and standing, Actigraph is able to better classify activity intensities. Moreover, as recommended in different research, I use the Actigraph in my PhD to objectively asses 24-hour movement behaviors. Given these considerations, the aim of this study is to validate the DABQ against the Actigraph as the reference method. Furthermore, this study aims to analyze the data as compositional data, which would provide a more comprehensive understanding of the interrelatedness of behaviors. The hypothesis is that there will be moderate convergent validity between the DABQ and Actigraph, allowing for accurate assessment of sleep duration, SB, LPA, and MVPA. By establishing the validity of the DABQ and considering the data as compositional, researchers can utilize this questionnaire in time-use epidemiology studies, which could be seen as an easy to use and cost-effective measurement method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2023
CompletedFirst Submitted
Initial submission to the registry
February 26, 2024
CompletedFirst Posted
Study publicly available on registry
June 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedAugust 9, 2024
August 1, 2024
9 months
February 26, 2024
August 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Total 24-hour movement behaviors collected by the Actigraph GT3X+BT
The Actigraph GT3X+BT will objectively collect time spent in sleep, sedentary behavior and physical activity. This device will be worn be the participants during 7 consecutive days (at night at their non-dominant wrist and during the day at their right hip).
Through study completion, an average of 2 weeks
Total 24-hour movement behaviors collected by the Daily Activity Behavior Questionnaire (DABQ)
This questionnaire will subjectively collect time spent in sleep, sedentary behavior and physical activity. This questionnaire will be filled in at the end of the 7 days wearing the Actigraph mentioned in outcome 1.
Through study completion, an average of 2 weeks
Convergent validity between time spent in 24-hour movement behaviors collected by the Actigraph GT3X+BT and DABQ
Intraclass correlation coefficient (95% confidence intervals) and pearson/spearman correlation will be used to measure the convergent validity and intermeasurement reliability. This method allows the comparison between self-reported use of time and the device measured use of time for each behavior separately.
Through study completion, an average of 2 weeks
Secondary Outcomes (12)
Participant characteristics "sex" potentially explaining biases in reporting 24-hour movement behaviors.
Through study completion, an average of 2 weeks
Participant characteristics "age" potentially explaining biases in reporting 24-hour movement behaviors.
Through study completion, an average of 2 weeks
Participant characteristics "body mass index" potentially explaining biases in reporting 24-hour movement behaviors.
Through study completion, an average of 2 weeks
Participant characteristics "family situation" potentially explaining biases in reporting 24-hour movement behaviors.
Through study completion, an average of 2 weeks
Participant characteristics "children" potentially explaining biases in reporting 24-hour movement behaviors.
Through study completion, an average of 2 weeks
- +7 more secondary outcomes
Study Arms (1)
Adults
OTHERIn this study, participants will have one contact session with the researcher, which will be held either at Ghent University Hospital or at the participants' home. During this session, participants will be provided with an accelerometer device and two questionnaires (to be filled in after wearing the Actigraph), namely the Daily Activity Behavior Questionnaire (DABQ) and general information questionnaire. The participants will receive an Actigraph wGT3X+BT accelerometer which will be worn for seven consecutive days. Instructions will be given on how to wear the accelerometer (e.g. during the day at the hip and during the night at the wrist). At the end of this week, the participants will fill in both questionnaires. After wearing the accelerometer for seven consecutive days and filling in both questionnaires, the researcher will visit the participants to collect the devices, or the participants will send them back by postal package.
Interventions
In this study, participants will have one contact session with the researcher, which will be held either at Ghent University Hospital or at the participants' home. During this session, participants will be provided with an accelerometer device and two questionnaires (to be filled in after wearing the Actigraph), namely the Daily Activity Behavior Questionnaire (DABQ) and general information questionnaire. The participants will receive an Actigraph wGT3X+BT accelerometer which will be worn for seven consecutive days. Instructions will be given on how to wear the accelerometer (e.g. during the day at the hip and during the night at the wrist). At the end of this week, the participants will fill in both questionnaires. After wearing the accelerometer for seven consecutive days and filling in both questionnaires, the researcher will visit the participants to collect the devices, or the participants will send them back by postal package.
Eligibility Criteria
You may qualify if:
- \- Adults between 18 and 65 years old
You may not qualify if:
- Physical (e.g. amputations, paralysis, recovering from stroke, osteoarthritis conditions that obstruct daily functioning
- Cognitive (e.g. dementia, psychological disorders) conditions that obstruct daily functioning
- Major medical (e.g. Chronic respiratory diseases, heart failure, cardiovascular diseases) conditions that obstruct daily functioning
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Study Sites (1)
Ghent university Hospital
Ghent, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marieke De Craemer
University Ghent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 26, 2024
First Posted
June 20, 2024
Study Start
September 30, 2023
Primary Completion
July 1, 2024
Study Completion
July 1, 2024
Last Updated
August 9, 2024
Record last verified: 2024-08